Naturelo Saw Palmetto Prostate Health
Naturelo Saw Palmetto Prostate Health, NPN 80122139: natural health product licensed in Canada. Medicinal ingredients: Prunus africana, Lycopène tout trans, (3-bêta)-stigmast-5-én-3-ol, Serenoa repens.
If this product were sold in France
- Legal conditions
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Legal conditions
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Legal conditions
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus africana Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 150 mg | 37.5 mg | Not calculated |
| Lycopène tout trans Source : Lycopène | 7.5 mg | Not calculated |
| (3-bêta)-stigmast-5-én-3-ol Source : Pinus pinaster - plante entière | 50 mg | Not calculated |
| Serenoa repens Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 150 mg | 37.5 mg | Not calculated |
| Brassica oleracea var. italica Source : Brassica oleracea var. italica - germe | 125 mg | Not calculated |
| Curcuminoïdes Source : Curcuma longa - rhizome | 23.75 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Hypromellose, Silicate de calcium, L-Leucine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Hommes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to support prostate health. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Formulated to Help Support Prostate Health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you have gallstones, a bile duct obstruction, stomach ulcers or excess stomach acid. Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use to exclude a diagnosis of prostate cancer. Keep out of reach of children.
Product record
- Other names
- Naturelo Saw Palmetto
- Licence holder
- Naturelo Premium Supplements, LLC.
- NPN or DIN-HM
- 80122139
- Status
- Inactive licence
- Licence date
- 25 November 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80122139
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Prunus africana
Read the warning, when it applies and the studies cited
PYGEUM - PRUNUS AFRICANA
Route of administration: Oral
Cautions and warnings
Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).
Sources cited by Health Canada (1)
- Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.
Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Serenoa repens
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Naturelo Saw Palmetto Prostate Health (Naturelo Premium Supplements, LLC.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80122139-naturelo-saw-palmetto-prostate-health, updated 25 November 2022.